Genetic basis of strain variation in levels of radiation-induced apoptosis of thymocytes

Radiation Research

Volumn 146, Issue 6, 1996, Pages 646-651

  Weil, Michael M ^a   Amos, Christopher I ^a   Mason, Kathryn A ^a   Stephens, L Clifton ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ETIOLOGY; GENETICS; HEREDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; STRAIN DIFFERENCE; THYMOCYTE;

ANIMALIA;

EID: 0029850592     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579380     Document Type: Article

References (37)

1. I. Turesson, Individual variation and dose dependency in the progression rate of skin telangiectasia. Int. J. Radiat. Oncol. Biol. Phys. 19, 1569-1574 (1990).
2. S. L. Tucker, I. Turesson and H. D. Thames, Evidence for individual differences in the radiosensitivity of human skin. Eur. J. Cancer 28A, 1783-1791 (1992).
3. A. M. Taylor, D. G. Harnden, C. F. Arlett, S. A. Harcourt, A. R. Lehmann, S. Stevens and B. A. Bridges, Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258, 427-429 (1975).
4. R. M. Hart, B. F. Kimler, R. G. Evans and C. H. Park, Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int. J. Radiat. Oncol. Biol. Phys. 13, 1237-1240 (1987).
5. R. Abadir and N. Hakami, Ataxia telangiectasia with cancer. An indication for reduced radiotherapy and chemotherapy doses. Br. J. Radiol. 56, 343-345 (1983).
6. P. J. Deschavanne, D. Debieu, B. Fertil and E. P. Malaise, Re-evaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins. Int. J. Radiat. Biol. 50, 279-293 (1986).
7. W. G. Woods, T. D. Byrne and T. H. Kim, Sensitivity of cultured cells to gamma radiation in a patient exhibiting marked in vivo radiation sensitivity. Cancer 62, 2341-2345 (1988).
8. F. Geara, L. J. Peters, K. K. Ang, J. L. Wike and W. A. Brock, Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 27, 1173-1179 (1993).
9. J. Johansen, S. M. Bentzen, J. Overgaard and M. Overgaard, Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int. J. Radiat. Biol. 66, 407-412 (1994).
10. N. G. Burnet, J. Nyman, I. Turesson, R. Wurm, J. R. Yarnold and J. H. Peacock, The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother. Oncol. 33, 228-238 (1995).
11. W. A. Brock, S. L. Tucker, F. B. Geara, I. Turesson, J. Wike, J. Nyman and L. J. Peters, Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 32, 1371-1379 (1995).
12. H. Frölén, K. G. Lüning and C. Rönnbäck, The effect of x-irradiation on various mouse strains due to their genetic background. Radiat. Res. 14, 381-393 (1956).
13. D. Grahn, Acute radiation response of mice from a cross between radiosensitive and radioresistant strains. Genetics 43, 835-843 (1958).
14. 50 and death rate studies. Radiat. Res. 5, 309-317 (1956).
15. D. P. Doolittle, The effect of single gene substitutions on resistance to radiation in mice. Genetics 46, 1501-1509 (1961).
16. J. D. Down, D. Nicholas and G. G. Steel, Lung damage after hemithoracic irradiation: dependence on mouse strain. Radiother. Oncol. 6, 43-50 (1986).
17. A. J. Franko, J. Sharplin, W. F. Ward and J. M. Hinz, The genetic basis of strain-dependent differences in the early phase of radiation injury in mouse lung. Radiat. Res. 126, 349-356 (1991).
18. N. Mori, M. Okumoto, J. Morimoto, S. Imai, T. Matsuyama, Y. Takamori and O. Yagasaki, Genetic analysis of susceptibility to radiation-induced apoptosis of thymocytes in mice. Int. J. Radiat. Biol. 62, 153-159 (1992).
19. N. Mori, M. Okumoto, M. A. van der Valk, S. Imai, S. Haga, K. Esaki, A. A. Hart and P. Demant, Genetic dissection of susceptibility to radiation-induced apoptosis of thymocytes and mapping of Rapop1, a novel susceptibility gene. Genomics 25, 609-614 (1995).
20. N. Mori, M. Okumoto, A. A. Hart and P. Demant, Apoptosis susceptibility genes on mouse chromosome 9 (Rapop2) and chromosome 3 (Rapop3). Genomics 30, 553-557 (1995).
21. L. C. Stephens, N. R. Hunter, K. K. Ang, L. Milas and R. E. Meyn, Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat. Res. 135, 75-80 (1993).
22. L. C. Stephens, K. K. Ang, T. E. Schultheiss, L. Milas and R. E. Meyn, Apoptosis in irradiated murine tumors. Radiat. Res. 127, 308-316 (1991).
23. S.A.G.E., Statistical Analysis for Genetic Epidemiology, Release 2.2. Department of Biostatistics and Epidemiology, Case Western Reserve University, Cleveland, OH, 1994.
24. G. W. Snedecor and W. G. Cochran, Statistical Methods, 7th ed. Iowa State University Press, Ames, 1980.
25. H. Akaike, Prediction and entropy. In A Celebration of Statistics (A. C. Atkinson and S. E. Fienberg, Eds.), pp. 1-24. Springer, New York, 1985.
26. K. Ijiri and C. S. Potten, The circadian rhythm for the number and sensitivity of radiation-induced apoptosis in the crypts of mouse small intestine. Int. J. Radiat. Biol. 58, 165-175 (1990).
27. A. M. Duncan, A. Ronen and D. H. Blakey, Diurnal variation in the response of gamma-ray-induced apoptosis in the mouse intestinal epithelium. Cancer Lett. 21, 163-166 (1983).
28. H. Teshima, H. Kihara, H. Sogawa, M. Iric and T. Nakagawa, Disturbances in the circadian rhythm of T cell subsets in stressed mice. Ann. NY Acad. Sci. 650, 288-292 (1992).
29. N. Mori, R. Nishikawa, M. Okumoto, K. Nishikawa, S. Imai, N. Narita, Y. Takamori and O. Yagasaki, Strain difference in the susceptibility of thymocytes to radiation-induced apoptosis: in vitro study. J. Radiat. Res. 32, 277-285 (1991).
30. R. Watanabe-Fukunaga, C. I. Brannan, N. G. Copeland, N. A. Jenkins and S. Nagata, Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317 (1992).
31. T. Takahashi, M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda and S. Nagata, Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976 (1994).
32. F. Rieux-Laucat, F. Le Deist, C. Hivroz, I. A. Roberts, K. M. Debatin, A. Fischer and J. P. de Villartay, Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349 (1995).
33. S. Ghosh, S. M. Palmer, N. R. Rodrigues, H. J. Cordell, C. M. Hearne, R. J. Cornall, J-B. Prins, P. McShane, G. M. Lathrop, L. B. Peterson, L. S. Wicker and J. A. Todd, Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nature Genet. 4, 404-409 (1993).
34. K. Leijon, B. Hammarstrom and D. Holmberg, Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. Int. Immunol. 6, 339-345 (1994).
35. C. Penha-Goncalves, K. Leijon, L. Persson and D. Holmberg, Type 1 diabetes and the control of dexamethazone-induced apoptosis in mice maps to the same region on chromosome 6. Genomics 28, 398-404 (1995).
36. W. Dietrich, H. Katz, S. E. Lincoln, H. S. Shin, J. Friedman, N. C. Dracopoli and E. S. Lander, A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131, 423-447 (1992).
37. E. S. Lander and N. J. Schork, Genetic dissection of complex traits. Science 265, 2037-2048 (1994).